leading biotech company for glp-1 Drugs: The Science and the Scarcity @kiranmazumdar_shaw is the Executive Chairperson

Name: leading biotech company for glp-1 Drugs: The Science and the Scarcity @kiranmazumdar_shaw is the Executive Chairperson
Brand: capewinelands.gov.za
SKU: 19939050154
Price: 22.28 USD
Availability: InStock
Rating: 4.6066 (29 reviews)

SKU: 19939050154

4.6

EUR22.28 EUR45.28

Pay in 4 interest-free payments of $5.57 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

@kiranmazumdar_shaw is the Executive Chairperson of Biocon Limited, one of Indias leading biotechnology companies., She is widely recognized as a pioneer of Indias biotech industry and has played a Top 30 Pharma Companies in 2023: Statistics and Trends Xtalks Middle East & Africa Glucagon like Peptide 1 (GLP 1) Agonists Market Report Market Overview: GLP 1 Agonists and the Obesity Market Blog Ozmosi GLP 1 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 BioSpace

Store: capewinelands.gov.za · Domain: capewinelands.gov.za

Description

According to NICE guidance (NG28) , GLP-1 agonists are recommended for type 2 diabetes when metformin and other treatments have not achieved adequate control

About 4% of Americans were taking GLP-1 receptor agonists in 2024 for either overweight, obesity, or type 2 diabetes, one research paper found